Bouchra Asli

2.5k citations
30 papers · 1.1k indexed · h-index 15
Topics
Multiple Myeloma Research and Treatments (6 papers)Chronic Lymphocytic Leukemia Research (5 papers)Platelet Disorders and Treatments (5 papers)
Partner nations
FranceUnited StatesItaly

In The Last Decade

Bouchra Asli

28 papers receiving 1.1k citations

Peers

Bouchra Asli
Comparison fields: 5 of 56
  • Molecular Biology 618
  • Hematology 358
  • Rheumatology 259
  • Genetics 256
  • Immunology 206
Replace Pascal Godmer with:
Pascal Godmer France
I. Koetter Germany
Luis Felipe Flores-Suárez Mexico
Loukas Settas Greece
Patrycja Hoffmann United States
Claudia A. Müller Germany
A. Léon France
Katsumichi Fujimaki Japan
Masamitsu Karasawa Japan
Sandra Muñoz Spain
Bouchra Asli relative to Pascal Godmer France Pascal Godmer's profile →
Citations per field
00.5×3.3×
Pascal Godmer · 1×
Citations per year

Countries citing papers authored by Bouchra Asli

Since Specialization
Citations

This map shows the geographic impact of Bouchra Asli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bouchra Asli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bouchra Asli more than expected).

Fields of papers citing papers by Bouchra Asli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bouchra Asli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bouchra Asli. The network helps show where Bouchra Asli may publish in the future.

Co-authorship network of co-authors of Bouchra Asli

This figure shows the co-authorship network connecting the top 25 collaborators of Bouchra Asli. A scholar is included among the top collaborators of Bouchra Asli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bouchra Asli. Bouchra Asli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 14
4 22
5 54
6 40
7 19
8 60
9 69
10 26
11 13
12 133
13 22
14 7
15 1
16 331
17 24
18 10
19 18
20 6

About Bouchra Asli

Bouchra Asli is a scholar working on Hematology, Genetics and Nephrology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Platelet Disorders and Treatments (5 papers). The work is most often cited by research in Hematology (358 citations), Genetics (256 citations) and Rheumatology (259 citations). Bouchra Asli has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Jean‐Paul Fermand, Jean‐Charles Piette, Marion Malphettes, Arnaud Jaccard, Frank Bridoux, Bruno Royer, Véronique Leblond, Olivier Hermine, Philippe Moreau and Christian Récher. Their work appears in journals such as New England Journal of Medicine, Blood and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026